A Win For BELLUS Health Inc.
BELLUS Health Inc. (BLU:NASDAQ) jumped higher at $14.44, representing a gain of 98.9%. On Tue, Apr 18, 2023, BLU:NASDAQ touched a New 2-Week High of $14.44. The stock appeared on our News Catalysts scanner on Tue, Apr 18, 2023 at 05:58 PM in the 'ACQUISITION' category. From Tue, Apr 04, 2023, the stock recorded 66.67% Up Days and 60.00% Green Days
About BELLUS Health Inc. (BLU:NASDAQ)
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, development of drug candidates for health solutions.
Top 10 Gainers:
- BELLUS Health Inc. (BLU:NASDAQ), 98.9%
- Agrify Corporation (AGFY:NASDAQ), 73.91%
- Oblong Inc. (OBLG:NASDAQ), 61.21%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 60.13%
- Super League Gaming, Inc. (SLGG:NASDAQ), 54.44%
- Gamida Cell Ltd. (GMDA:NASDAQ), 50.89%
- Glory Star New Media Group Holdings Limited (GSMG:NASDAQ), 47.92%
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 44.98%
- Petros Pharmaceuticals Inc. (PTPI:NASDAQ), 42.49%
- SAB Biotherapeutics Inc. (SABS:NASDAQ), 41.56%